Background
On 18 June 2025, the Medical Device Coordination Group (MDCG) released MDCG 20255, Questions & Answers regarding performance studies of in vitro diagnostic medical devices under regulation (EU) 2017/746. MDCG 2025-5 is a Questions & Answers document clarifying performance study requirements under the EU’s In Vitro Diagnostic Medical Devices Regulation (IVDR). This guidance is designed primarily for sponsors and manufacturers involved in performance studies of IVD medical devices (IVDs) ranging from analytical validation to clinical investigation.
Purpose
The document serves multiple objectives:
- Clarify study scope
It distinguishes between analytical performance studies (e.g., accuracy, precision) and clinical performance studies (e.g., sensitivity, specificity), outlining when each type is required or may be waived based on justification. - Guide regulatory pathways
It helps stakeholders determine whether a performance study must be applied for (e.g., for invasive procedures under Articles 58/70) or simply notified to competent authorities (e.g., studies with leftover samples). - Clarify roles and burden of proof
It reinforces that the manufacturer owns the device’s intended purpose, which shapes the performance study design and regulatory obligations. It also highlights the responsibility of sponsors to consider national ethical review alongside IVDR requirements. - Clarify special cases
It explains how to handle companion diagnostics, substantial modifications during ongoing studies, and criteria distinguishing performance studies from other research.
Why it matters
This guidance adds clarity to the complex field of performance studies under the IVDR. It provides advice to sponsors, manufacturers, and notified bodies and thus helps to ensure designs are compliant, risks are managed, and the evidence collected supports safety and performance claims.
The document can be downloaded from our website.
Source: European Commission
Accompanying this subject we recommend the following content on our website
- Sponsors are now invited to apply for the EU’s pilot programme aimed at expediting clinical investigations and performance studies
- The European Union simplifies the management of multinational combination product trials
- Templates on hand for sponsors of IVD performance studies





